FCMI
INSM icon

Foresite Capital Management IV’s Insmed INSM Stock Holding History

Foresite Capital Management IV’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-300,000
Closed -$6.8M – 18
2018
Q1 		$6.8M Buy
+300,000
New +$7.9M 2.82% 14

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Foresite Capital Management IV's INSM Position: Q2 2020 in Review

Foresite Capital Management IV sold out of Insmed (INSM) in Q2 2020, closing a stake of 678,322 shares — an estimated $10.9M sold.

Foresite Capital Management IV first reported a position in INSM in Q4 2017 and held it in 10 quarters. The position peaked at $44.6M in Q1 2019. 191 funds tracked by Wall St. Rank hold INSM as of Q2 2020.

  • Foresite Capital Management IV reported no remaining Insmed position as of Q2 2020 after selling out during the quarter.
  • Foresite Capital Management IV sold 678,322 Insmed shares in Q2 2020, an estimated $10.9M.
  • Foresite Capital Management IV first reported a position in Insmed in Q4 2017 and held it in 10 quarters.
  • Foresite Capital Management IV's Insmed position peaked at $44.6M in Q1 2019.
  • 191 funds tracked by Wall St. Rank held Insmed as of Q2 2020.

Based on Foresite Capital Management IV's 13F filing for Q2 2020, filed 13 Aug 2020.